Akums Q4 revenue climbs to Rs. 1,158 crore; PAT surges 135%
FY26 revenue rises to Rs. 4,359 crore as India’s leading CDMO strengthens global footprint with EU GMP certifications, UK MHRA approval and Europe supplies
FY26 revenue rises to Rs. 4,359 crore as India’s leading CDMO strengthens global footprint with EU GMP certifications, UK MHRA approval and Europe supplies
Akums bridges the long-standing gap between paediatric syrups and conventional tablet formats
The new combination therapy offers a dual mechanism of action for superior intraocular pressure control
The facility is equipped with state-of-the-art technology to produce high-quality lyophilized (freeze-dried) products
Subscribe To Our Newsletter & Stay Updated